For patients with early-stage #BreastCancer, biomarkers, such as BRCA, HR, and HER2, may provide valuable information about their disease. Testing for #biomarkers at diagnosis may help inform your treatment planning.
Approximately 30% of patients diagnosed with early-stage #BreastCancer eventually develop recurrent advanced or metastatic disease.
Consider your treatment options to help reduce their risk of recurrence.
@RRRachelRRRom Rachel, This content is intended for US healthcare professionals only. The best person to speak with about this will be your doctor. Take care.
@lakeloon5 Thanks for reaching out. We're educating healthcare providers about the importance of testing for certain biomarkers and how they may inform treatment decisions in early-stage breast cancer. For more information, please visit https://t.co/IKS9dT7fQf. Be well.
Test for #biomarkers, such as BRCA, HR, and HER2, at diagnosis for your early-stage #BreastCancer patients.
#BreastCancerAwarenessMonth is a great time to explore how biomarker testing may help guide your treatment approach for curative intent.
Test for #biomarkers, such as BRCA, HR, and HER2, at diagnosis for your early-stage #BreastCancer patients.
#BreastCancerAwarenessMonth is a great time to explore how biomarker testing may help guide your treatment approach for curative intent.
@bodaciousbrains Thanks for your question. We're educating healthcare providers about the importance of testing for certain biomarkers and how they may inform treatment decisions in early-stage breast cancer. For more information, please visit https://t.co/IKS9dT7fQf. Take care.
@Mateo3032@Mateo3032 Unfortunately, we arenβt able to comment in regard to
specific cancers, medications, or remedies. Thanks for reaching out. Be well.
@maureenmcardle@maureenmcardle This content is intended for US healthcare
professionals only. The best person to speak with about this
will be your doctor. Thanks for reaching out. Be well.